King of Prussia, PA, United States of America

Miljenko Mervic


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 116(Granted Patents)


Company Filing History:


Years Active: 1995-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Miljenko Mervic: Innovations in Peptide Inhibitors of Inflammation

Introduction

Miljenko Mervic, an accomplished inventor based in King of Prussia, PA, has made significant strides in the field of biomedical research. With a portfolio of four patents, his work primarily focuses on developing peptide inhibitors that address inflammation by inhibiting selectin-mediated adhesion of neutrophils.

Latest Patents

Mervic's latest patents include groundbreaking innovations such as "Peptide inhibitors of inflammation mediated by selectins" and "Peptide inhibitors of selectin binding." These inventions describe peptides derived from the lectin domain of GMP-140 (P-selectin) and other selectins. The peptides have demonstrated efficacy in inhibiting neutrophil adhesion, showcasing biological activity despite variations in their core sequence and terminal flanking regions. Additionally, Mervic's work underlines the potential clinical applications of these peptides in modulating coagulation and inflammatory processes, both as diagnostics and therapeutic agents.

Career Highlights

Throughout his career, Miljenko Mervic has worked with notable organizations, including Centocor, Inc. and the University of Oklahoma. His involvement in these institutions has allowed him to further his research and develop innovative solutions to complex biomedical challenges.

Collaborations

Mervic's work has benefitted from collaborations with distinguished colleagues such as George A Heavner and Marian Kruszynski. These partnerships have played a vital role in the progress and impact of his inventions within the scientific community.

Conclusion

Miljenko Mervic's contributions to the field of peptide inhibitors exemplify the critical intersection of innovation and healthcare. His patents not only advance our understanding of inflammation but also open doors for new therapeutic approaches. As biomedical research continues to evolve, Mervic's innovations will undoubtedly influence future developments in this vital area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…